Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.41
- Piotroski Score 3.00
- Grade N/A
- Symbol (BIMI)
- Company BIMI International Medical Inc.
- Price $0.01
- Changes Percentage (0%)
- Change -$0
- Day Low $0.01
- Day High $0.01
- Year High $4.13
BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/25/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$6.39
- Trailing P/E Ratio -0.22
- Forward P/E Ratio -0.22
- P/E Growth -0.22
- Net Income $-22,352,754
Income Statement
Quarterly
Annual
Latest News of BIMI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Bimini Capital Management Inc (BMNM) Q3 2024 Earnings Call Highlights: Strong Net Income and ...
Bimini Capital Management reported a net income of $17.3 million in Q3 2024, with shareholders' equity rising to $656 million. RMBS portfolio grew by 28%, funding costs stable. Market re-evaluating ec...
By Yahoo! Finance | 2 weeks ago -
S7, Ep7: Bimini Bon-Boulash, drag queen
Grace is joined by Bimini Bon-Boulash, a popular UK drag queen known for their wit, fashion sense, and talent. Despite not winning RuPaul's Drag Race UK, Bimini has gained a large following and succes...
By The Guardian | 3 months ago
